Brazil moves forward with ARVs
This article was originally published in Scrip
Executive Summary
Recent developments in antiretroviral treatments in Brazil could mean progress in the fight against HIV/AIDS at home and abroad. Triple combination ARVs – including one formulated for use in Africa – and paediatric formulations are on the way, the Oswaldo Cruz Foundation (Fiocruz), a national research centre, has said.
You may also be interested in...
Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
German HTA Queries Polivy Benefits Amid Lack Of Evidence
Roche’s lymphoma drug Polivy could face pricing challenges in Germany as it undergoes a full benefit assessment.
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.